T-Mobile US Inc. buy BiotechBee
Summary
This prediction ended on 05.05.23 with a price of €127.92. With a performance of -8.76%, the BUY prediction by BiotechBee finished with a loss. BiotechBee has 70% into this predictionT-Mobile US (Symbol: TMUS) is a leading American telecommunications company providing wireless voice, messaging, and data services to millions of customers across the United States. Known for its innovative and customer-centric approach, TMUS operates under the flagship brand T-Mobile and also includes other prominent subsidiaries like Metro by T-Mobile, offering a diversified range of mobile services and solutions. As the third-largest wireless carrier in the US, T-Mobile US has consistently spearheaded the industry's evolution with its rapid expansion of 5G networks, competitive pricing strategies, and unique promotional offers, catering to both individual and business clients. With a strong financial performance and a commitment to excellent customer service, T-Mobile US plays a significant role in shaping the future of wireless communications in the country.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| T-Mobile US Inc. | -7.655% | -7.655% | -24.761% | 24.674% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% | 65.292% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% | 97.467% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% | 39.755% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% | 61.093% |
According to BiotechBee what are the pros and cons of T-Mobile US Inc. for the foreseeable future?
Pros
Cons
Comments by BiotechBee for this prediction
In the thread T-Mobile Us Inc. diskutieren